Abbott and Sherri Shepherd: Millions Not Using Affordable Diabetes Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Abbott Laboratories (NYSE: ABT) | Delayed: 102.84 +0.33 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.51 | 52 Week High | $46.38 | |||
| Open | $102.28 | 52 Week Low | $36.00 | |||
| Day High | $103.70 | P/E | 68.56 | |||
| Day Low | $101.56 | EPS | $1.50 | |||
| Volume | 1,766,620 | |||||
